Who governs.Who is accountable.
Who governs. Who is accountable. The leaders defining the AI Officer in life sciences, across AI governance, drug discovery and clinical AI.
2027 · Two editions · Berlin in February · London in May · Invited audience
A model proven in one function changes little until the next function trusts its output. Pilots succeed in isolation and stall at the handover.
The organisations that deploy AI at scale are the ones that look along the whole chain and give it an owner. AI deploys when the chain has an owner. This is the room where it finds one.
the Conversation. AIO is that conversation. It is carried into the rooms the Circle already convenes, rather than asking the same leaders to clear two more days. Less noise. More signal.
In the Circle. The leaders who own a link in the chain and choose the platforms, data and partners that carry AI through it: research, process, quality, operations, supply and the executive who answers for all of them.
AI now shapes decisions from the first molecule to the last shipment. Each link in the chain has an owner. The chain itself has none. That is where deployment stalls.
One conversation. It opens in Berlin in February, at the plant, where accountability is already law. It continues in London in May, upstream into discovery and downstream into supply. What Berlin decides, London tests. Each sitting takes the question as the last one left it.
Who governs. Who decides. Who is accountable.
Harsukh Parmar
Chair · AIO Circle · Former SVP Global Head of Research · Merck KGaA
The chair opens the Circle and holds the line of the conversation on AI accountability.
The room.
By invitation. By relevance. By room.
In the room.
